The Initiative

The MY ANSWER TO CANCER initiative was initially launched to generate philanthropic support for projects specific to personalized targeted cancer treatment. We later realized that everything we do at Moores Cancer Center supports this profound commitment to finding cures, treating disease, and delivering care in a very customized approach for our family and friends with cancer. Now, all of our fundraising programs at Moores Cancer Center will come under the larger MY ANSWER TO CANCER umbrella as a reminder of the partnership that philanthropy requires.  

 

Personalized Cancer Treatment

For most metastatic cancers, traditional therapies increase survival by only a few months. Furthermore, many treatments––surgery, radiation, and standard chemotherapy––are toxic and disfiguring. Patients tell us they are not sure if the cancer or the treatment is worse. This must and can change!

Fortunately, our understanding of cancer is advancing at an astounding rate. Scientists have discovered the abnormal pathways that drive cancer cells to grow and invade. Potent drugs that specifically suppress these abnormal signals and, hence, kill cancer cells without causing significant damage to normal tissue are becoming available. These drugs often have very few to no side effects.

However, it is crucial to recognize that these potent, molecularly targeted compounds may produce a response only in patients who bear the specific abnormal signal capable of being modulated by that agent. Because each patient’s cancer may be different, it's essential to analyze the DNA of each tumor and choose the best drugs for that individual. By using powerful computer technology, our scientists will rapidly learn from the tremendously complicated information gathered from each of these analyses to design even better personalized treatment strategies for each future patient.

The old treatment model of diagnosing cancer by peering into a “light” microscope (an instrument invented in 1590) is no longer adequate. In order to move forward in leaps rather than small increments, we must use the “molecular microscope” of the 21st century, and create alongside it a giant databank that will quickly drive new discoveries for patients with cancer.

We have the drugs. We have the technology. We have the physicians and scientists. And we have a plan of attack: MY ANSWER TO CANCER. If we can put the resources in place, we can now change the face of cancer.